Review: taking Suboxone and Effexor together


Summary

Drug interactions are reported among people who take Suboxone and Effexor together. This review analyzes the effectiveness and drug interactions between Suboxone and Effexor. It is created by eHealthMe based on reports of 299 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in drug dependence. (latest outcomes from Suboxone 15,624 users)

Effexor

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. (latest outcomes from Effexor 69,031 users)

On Sep, 17, 2016

299 people who take Suboxone, Effexor are studied.


Number of reports submitted per year:

Suboxone and Effexor drug interactions.

Drug effectiveness over time:

Suboxone:
  • < 1 month: 42.0% - (3 of 7 people)
  • 1 - 6 months: 100.0% - (7 of 7 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 60.0% - (6 of 10 people)
  • 2 - 5 years: 83.0% - (5 of 6 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Effexor:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 50.0% - (4 of 8 people)
  • 1 - 2 years: 25.0% - (1 of 4 people)
  • 2 - 5 years: 46.0% - (6 of 13 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Suboxone:
  • female: 70.0% - (14 of 20 people)
  • male: 66.0% - (10 of 15 people)
Effexor:
  • female: 39.0% - (9 of 23 people)
  • male: 42.0% - (6 of 14 people)

Drug effectiveness by age:

Suboxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 70.0% - (7 of 10 people)
  • 30-39: 76.0% - (13 of 17 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 100.0% - (2 of 2 people)
Effexor:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 15.0% - (2 of 13 people)
  • 30-39: 53.0% - (8 of 15 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • abasia
  • aphasia
  • psychomotor skills impaired
  • asthenia
  • drug withdrawal syndrome
  • insomnia
  • cardiac failure congestive
  • constipation
  • decreased appetite
  • fall
1 - 6 months:
  • blurred vision
  • frustration
  • somnolence
  • cerebrovascular accident
  • contusion
  • cough
  • dizziness
  • drug withdrawal syndrome
  • drug withdrawal syndrome neonatal
  • fall
6 - 12 months:
  • feeling abnormal
  • bipolar disorder
  • drug withdrawal syndrome neonatal
  • fall
  • cardiac disorder
  • drug withdrawal syndrome
  • dyspnoea
  • hypoaesthesia
  • memory impairment
  • suicidal ideation
1 - 2 years:
  • drug withdrawal syndrome
  • bipolar disorder
  • cardiac disorder
  • chest pain
  • dyspnoea
  • fall
  • feeling abnormal
  • foetal exposure during pregnancy
  • hypoaesthesia
  • memory impairment
2 - 5 years:
  • drug withdrawal syndrome
  • fatigue
  • bad dreams
  • can't urinate
  • cervix carcinoma
  • dizziness aggravated
  • emotional disorder
  • foetal exposure during pregnancy
  • hallucination
  • hearing loss
5 - 10 years:
  • blurred vision
  • lethargy
  • drug withdrawal syndrome
  • insomnia
  • irritability
  • malaise
  • nausea
  • personality change
  • fatigue
10+ years:
  • lethargy
  • cellulitis
  • drug addiction
  • headache
  • insomnia
  • itchiness
  • low back pain
  • memory impairment
  • weight gain poor
not specified:
  • fatigue
  • drug withdrawal syndrome
  • depression
  • vomiting
  • pain
  • abdominal pain
  • gallbladder disorder
  • dyspepsia
  • somnolence
  • insomnia

Most common drug interactions by gender *:

female:
  • fatigue
  • drug withdrawal syndrome
  • depression
  • gallbladder disorder
  • abdominal pain
  • dyspepsia
  • abdominal tenderness
  • white blood cell count increased
  • abdominal distension
  • back disorder
male:
  • pain
  • somnolence
  • insomnia
  • vomiting
  • influenza like illness
  • malaise
  • haematoma
  • withdrawal syndrome
  • constipation
  • dizziness

Most common drug interactions by age *:

0-1:
  • drug withdrawal syndrome neonatal
  • foetal exposure during pregnancy
  • low birth weight baby
  • premature baby
  • neonatal aspiration
10-19:
  • drug ineffective
  • somnolence
  • anxiety
  • attention deficit/hyperactivity disorder
  • deep vein thrombosis
  • depression
  • post-traumatic stress disorder
  • protein s deficiency
  • pulmonary embolism
20-29:
  • drug withdrawal syndrome
  • drug abuse
  • irritability
  • malaise
  • pulmonary embolism
  • road traffic accident
  • affect lability
  • depressed mood
  • drug dependence
  • euphoric mood
30-39:
  • drug withdrawal syndrome
  • constipation
  • pain
  • convulsion
  • insomnia
  • vomiting
  • depression
  • influenza like illness
  • somnolence
  • emotional disorder
40-49:
  • depression
  • chest pain
  • bone pain
  • lymphadenopathy
  • cellulitis
  • alopecia
  • arthralgia
  • bronchitis
  • dysphagia
  • general physical health deterioration
50-59:
  • suicidal ideation
  • feeling abnormal
  • memory impairment
  • fall
  • fatigue
  • bipolar disorder
  • dyspnoea
  • cardiac disorder
  • drug withdrawal syndrome
  • frustration
60+:
  • fatigue
  • abdominal distension
  • abdominal pain
  • abdominal tenderness
  • back disorder
  • dyspepsia
  • gallbladder disorder
  • haemorrhage
  • inflammation
  • intestinal perforation

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Suboxone and Effexor?

Can you answer these questions?

More questions for: Suboxone, Effexor

You may be interested in these reviews

More reviews for: Suboxone, Effexor

On eHealthMe, Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Effexor (venlafaxine hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.